CVC Single Lumen 14g*8cm
These catheters offer more prominent implantation rates and upgraded over the wire situation. The plastic clasps are anything but difficult to handle and crimp safe. The offered scope of Central Venous Catheter Single Lumen Kit is accessible in French measurements furthermore in altered lengths for unique techniques.
Features
- These are designed with extreme precision
- These are easy to operate and safe to use
- The product comes with assured guarantee
- These are available in a competitive price
Related products
-
GUIDING CATHETER EKARI
Product Overview
IMPROVED BACK UP SUPPORT*1
Catheter designed to use contralateral wall resulting in enhanced back-up support.
UNIVERSAL SHAPE (IKARI LEFT)Â *2
Offer capability of accessing the right and left coronary arteries, potentially avoiding catheter exchanges.
DESIGN FOR SAFETY
Soft tip to reduce damage to the vessel wall
*1: Ikari Y, Nagaoka M, Kim JY, Merino Y, Tanabe T. The physics of guiding catheters for the left coronary artery in transfemoral and trans-radial interventions. J Invasive Cardio. 2005 Dec; 17(12): 636-641.*2: Youssef AA, Hsieh YK, Cheng CI, We CJ. A single trans-radial guiding catheter for right and left coronary angiography and intervention. Euro intervention 2007; 3: 475-481.
Patients who have had cardiac catheterization or coronary angioplasty often are required to stay in bed with restricted movement for three to 24 hours afterward to prevent bleeding from the femoral artery catheter insertion site.
Features and Benefits
Improved back up support in comparison to Terumo standard femoral guiding catheter shapes*1
*1: Based on comparative studies made among Terumo Guiding Catheters*2: Ekari Y, Nagaoka M, Kim JY, Merino Y, Tanabe T. The physics of guiding catheters for the left coronary artery in transfemoral and trans-radial interventions. J Invasive Cardio. 2005 Dec; 17(12): 636-641.*3: Youssef AA, Hsieh YK, Cheng CI, We CJ. A single trans-radial guiding catheter for right and left coronary angiography and intervention. Euro intervention 2007; 3: 475-481.
Guide catheters are required for all coronary interventions to provide access to the coronary ostium and support equipment delivery. The ideal guide provides stability for device advancement through the coronary anatomy, while minimizing vessel trauma and allowing for vessel opacification.
The catheter is guided to the narrowed artery. Then, a smaller balloon catheter is inserted through the flexible catheter and inflated at the narrowed area to open it. Often, the doctor will also place a mesh coil called a stent at the narrowed part to help keep the artery open.
-
PTCA Balloon Ryurei
Description
Confidence in your hands
Ryureiâ„¢ has superior crossability1Â thanks to the combination of low distal profiles and Terumo’s hydrophilic M coating. The short balloon bonding and reinforced shaft1Â results in enhanced trackability1Â while maintaining excellent pushability1.
These features can increase physician’s confidence in success even during complex procedures.
CharacteristicsExcellent Pusability
The combination of flexible distal part, tapered core wire on the midshaft and the thick proximal hypotube, results in smooth and balanced transition across the entire catheter for high transmission force, resulting in excellent pushability
Superior Crossability2
Thanks to the combination of distal low profiles and the Terumo hydrophilic M-Coat, Ryurei offers low friction in crossing tight lesions
Enhanced Trackability2
With an optimal tip design and improved balloon bonding, Ryurei provides enhanced trackability, even in tortuous anatomy and difficult to navigate vessels.
General specifications
​Shaft diameter ​1.9 Fr/0.64 mm Proximal • 2.5 Fr/0.84 mm Middle • 2.4 Fr/0.79 mm to 2.7 Fr/0.89 mm (tapered) Distal (1.00 to 1.50 mm) • 2.6 Fr/0.87 mm Distal (2.00 to 4.00 mm) ​Usable length ​145 cm ​Balloon markers # ​1(Ø1.0 to Ø 1.5 mm) • 2(Ø2.0 to Ø4.0 mm) ​Nominal pressure ​6 atm / 608 kPa ​Rated burst pressure Ø1.0 – 3.0 mm=14 atm(1419kPa) • Ø3.25 – 4.0 mm = 12 atm(1216 kPa) ​Guidewire compatibility ​Maximum diameter: 0.014″ / 0.36 mm ​Lesion entry profile ​0.41 mm (Ø1.00 to Ø1.50 mm) • 0.43 mm (Ø2.00 to Ø4.00 mm) ​Coating ​Hydrophilic Item specifications
Balloon length / Product code​​ ​ ​ ​ ​ ​
Balloon Diameter 5 mm 10 mm 15 mm 20 mm 30 mm 40 mm 1.00 mm DC-RR1005HH ​1.25 mm ​DC-RR1205HH ​​DC-RR1210HH ​​DC-RR1215HH ​​DC-RR1220HH ​ ​ 1.50 mm DC-RR1505HH DC-RR1510HH DC-RR1515HH DC-RR1520HH 2.00 mm DC-RR2010HHW DC-RR2015HHW DC-RR2020HHW DC-RR2030HHW DC-RR2040HHW 2.25 mm DC-RR2210HHW DC-RR2215HHW DC-RR2220HHW 2.50 mm DC-RR2510HHW DC-RR2515HHW DC-RR2520HHW DC-RR2530HHW DC-RR2540HHW 2.75 mm DCRR2710HHW DC-RR2715HHW DC-RR2720HHW 3.00 mm DC-RR3010HHW DC-RR3015HHW DC-RR3020HHW DC-RR3030HHW DC-RR3040HHW 3.25 mm DC-RR3210HHW DC-RR3215HHW DC-RR3220HHW 3.50 mm DC-RR3510HHW DC-RR3515HHW DC-RR3520HHW DC-RR3530HHW DC-RR3540HHW 3.75 mm DC-RR3710HHW DC-RR3715HHW DC-RR3720HHW 4.00 mm DC-RR4010HHW DC-RR4015HHW DC-RR4020HHW References
1 Ryurei φ1.00-5mm compared to Tazuna 1.25-10 mm- Data on file ISCD-416-31-4
* For Ryurei Ø 1.00 mm – Ø 1.50 mm.
** For Ryurei Ø 1.00mm – 5mm ​2 Compared to Tazuna PTCA dilatation catheter
-
Glide sheath
Product overview
Expanding trans-radial access to include more patients
- Glide sheath Slender is designed with a proprietary thin-wall technology where the outside diameter is reduced by one French size while the inner-diameter equivalent is maintained.
- Glide sheath Slender is coated with Terumo’s proprietary hydrophilic coating, allowing for smooth insertion and removal.
Features and Benefits
The proprietary thin-wall technology and Terumo M Coat hydrophilic coating
- Per the American Heart Association, dedicated radial sheaths with hydrophilic coating combined with smaller diameter sheaths and a tapered tip design may reduce risk of arterial spasm and radial occlusion1
- Featuring Terumo’s proprietary hydrophilic coating, the Glide sheath Slender Sheath is the only thin-wall radial sheath on the market to demonstrate superior and consistent performance in lubricity and durability over time
The Glide sheath Slender Sheath is the only thin-wall sheath that demonstrated best in class performance in all of the American Heart Association’s identified critical features that lead to reduced spasm.
THE POWER OF TERUMO GLIDE TECHNOLOGYâ„¢: LUBRICITY OVER TIMES
Hydrophilic coating is critical to procedural success, Physicians need to trust that their sheath will be just as lubricous at the end of case as it is at the beginning.
The graph below demonstrates the results of recent benchtop testing. The lower the value, the more lubricious the coating. The straighter the line, the more consistent, and reliable, the performance.
Glide sheath Slender Sheath outperformed the other competitive sheaths in both key features: lubricity and lubricity over time.
Unmatched Clinical Evidence
- A meta-analysis of 10 clinical papers, involving 3,821 patients, demonstrated that use of Glide sheath Slender Sheath is associated with high rates of procedural success and low rates in performance related issues.
- In studies measuring patient comfort, patients who underwent percutaneous trans-radial procedures with the Glide sheath Slender Sheath reported none to low amounts of pain.
-
CLOSUREFAST
ClosureFastâ„¢Â
procedureMinimally invasive thermal
treatment for vein disease
and varicose veins.
The ClosureFast procedure uses radiofrequency energy or heat to close the diseased vein, which redirects blood flow to healthy veins, relieving symptoms.Before the procedure
You will have an ultrasound imaging exam of the leg being treated. This exam is important for assessing the diseased superficial vein and planning the procedure.
During the procedure
Your doctor will discuss the procedure with you. Here is a brief summary of what to expect:
- The ClosureFast procedure is performed on an outpatient basis. Your doctor will perform the ClosureFast procedure. Using an ultrasound, your doctor will position a catheter in the diseased vein through a small opening in the skin.
- The small catheter delivers heat to the vein wall, causing it to shrink and seal the vein. Once the diseased vein is closed, blood will reroute itself to other healthy veins.
After the procedure
- You will be taken to the recovery area to rest.
- Following the procedure, your doctor will apply a simple bandage over the insertion site and will give you compression stockings to aid in the healing process. Your doctor may encourage you to walk and to refrain from extended standing and strenuous activities for a period of time. The average patient typically resumes normal activities within a few days.1,2
- Your doctor will recommend follow-up care as needed.
-
Benefits of the ClosureFast procedure
- Relief of symptoms after two days, with a noticeable improvement in one to two week
- Minimally invasive outpatient procedure
- Less pain and bruising than laser treatment
- Faster recovery than laser treatment
- Proven results with positive patient experience
Â
- Rapid recovery — on average, patients resume normal activities within a few days
- Lasting results — the only radiofrequency energy procedure with published long-term clinical data demonstrating safety and efficacy, with a 91.9% closure rate at five years.4
Adverse events can include nerve injury, hematoma, phlebitis, thrombosis, and/or pulmonary embolism.
Type of therapy
Thermal shrinkage of the vein wall with radiofrequency energy or heatInpatient or outpatient procedure
Outpatient procedureOne- versus two-leg treatment
Typically, each leg will be treated in separate appointmentsNeedle sticks required
One needle stick for vein access. Typically, 5 to 10 needle sticks for anesthesia.Â
Typical post-treatment recovery
Healing of vein access site, anesthetic needle stick sites, and also healing of ablated vein sectionCompression hose
Required for approximately one weekProcedure success rate
91.9% after five years4ClosureFast procedure FAQ
Is the ClosureFast procedure painful?
Most patients report feeling little, if any, pain during the ClosureFast procedure.3 Your doctor will give you a local or regional anesthetic to numb the treatment area.
When can I return to normal activity?
Patients treated with the ClosureFast procedure may resume normal activity more quickly than patients who undergo surgical vein stripping or laser ablation. With the ClosureFast procedure, the average patient typically resumes normal activity within a few days.2 For a few weeks following the treatment, your vein specialist may recommend a regular walking regimen and suggest you refrain from strenuous activities (heavy lifting, for example) or prolonged periods of standing.
When will my symptoms improve?
Most patients report relief of symptoms after two days, with a noticeable improvement in one to two weeks.
Is there any scarring, bruising, or swelling after the procedure?
Most patients report limited to no scarring, bruising, or swelling following the ClosureFast procedure.3
How is the ClosureFast procedure different from endovenous lasers?
Both Closure Fast and lasers use thermal technology to deliver heat into the diseased vein, but they each use a different method of delivery. Despite their similarity in using heat, a 2009 study showed that the ClosureFast procedure is associated with lower rates of pain, bruising, and complications and a faster improvement in patients’ quality of life when compared to 980 nm laser ablation.4
How is the Closure Fast procedure different from vein stripping?
During vein stripping, incisions are made in the groin and calf, and a tool is threaded through the diseased vein to pull the vein out of the leg. With the ClosureFast procedure, only one small incision is made at the insertion site and the vein is then treated and left in place. ClosureFast is a minimally invasive approach that reduces the likelihood of pain and bruising, associated with vein stripping surgery.1
Is the ClosureFast procedure covered by insurance?
Many patients have access to the ClosureFast procedure through their insurance coverage plan. Insurance companies detail access to the ClosureFast procedure and other radiofrequency ablation procedures in coverage policies for varicose veins or chronic venous insufficiency. As with all healthcare procedures, you may also have some cost associated with receiving treatment, such as a copay or coinsurance. Please reach out to your insurance company to discuss your specific plan coverage and potential costs prior to seeking treatment
Quiernera –
The rapid normalisation of CA 125 corresponds with the long progression free period in our case where to buy priligy usa